---
figid: PMC8113849__fonc-11-593479-g0001
figlink: pmc/articles/PMC8113849/figure/F1/
number: F1
caption: 'Estrogen and estrogen receptor-mediated pathways in thyroid cancer. (a)
  PI3K/AKT/mTOR pathway: activation of PI3K promotes cell proliferation and differentiation.
  PTEN gene can prevent PI3K phosphorylation and promote apoptosis, while activation
  of Bcl-2 gene promotes cell proliferation; AKT can promote NF-κB nuclear translocation,
  activate target genes, and promote cell survival. (b) Ras/Raf/MEK/extracellular
  signal-regulated kinase (ERK) pathway: E2 can make mitogen-activated protein (MAP)
  kinase isoenzymes and ERK 1/2 strongly phosphorylated, and then promote the expression
  changes of apoptosis-related factors, such as Bcl-2, Bax, and cyclinD1, increasing
  the ability of cell proliferation and survival. ERα can interact directly with IQGAP1
  to phosphorylate ERK1/2 thereby promoting cell proliferation. (c) Reactive oxygen
  species (ROS)-related pathways: E2 can stimulate ROS production by acting on NOX4
  that may be located in the plasma membrane, endoplasmic reticulum, nuclear membrane,
  and mitochondria, and then ROS induces the overexpression of HIF-1α. (d) E2 increases
  cyclin D1 protein expression and reduces the expression of p27 and β-catenin by
  ERα. Overexpression of ERα or ERβ decreased the activity of PPARγ protein, thereby
  significantly promoting the proliferation and migration of thyroid cancer cells.
  TRIM16 has “anti-estrogen” activity, and its anti-estrogen action is mainly concentrated
  in ERβ.'
pmcid: PMC8113849
papertitle: Signal Pathway of Estrogen and Estrogen Receptor in the Development of
  Thyroid Cancer.
reftext: Jian Liu, et al. Front Oncol. 2021;11:593479.
pmc_ranked_result_index: '64945'
pathway_score: 0.9599948
filename: fonc-11-593479-g0001.jpg
figtitle: Estrogen and estrogen receptor-mediated pathways in thyroid cancer
year: '2021'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8113849__fonc-11-593479-g0001.html
  '@type': Dataset
  description: 'Estrogen and estrogen receptor-mediated pathways in thyroid cancer.
    (a) PI3K/AKT/mTOR pathway: activation of PI3K promotes cell proliferation and
    differentiation. PTEN gene can prevent PI3K phosphorylation and promote apoptosis,
    while activation of Bcl-2 gene promotes cell proliferation; AKT can promote NF-κB
    nuclear translocation, activate target genes, and promote cell survival. (b) Ras/Raf/MEK/extracellular
    signal-regulated kinase (ERK) pathway: E2 can make mitogen-activated protein (MAP)
    kinase isoenzymes and ERK 1/2 strongly phosphorylated, and then promote the expression
    changes of apoptosis-related factors, such as Bcl-2, Bax, and cyclinD1, increasing
    the ability of cell proliferation and survival. ERα can interact directly with
    IQGAP1 to phosphorylate ERK1/2 thereby promoting cell proliferation. (c) Reactive
    oxygen species (ROS)-related pathways: E2 can stimulate ROS production by acting
    on NOX4 that may be located in the plasma membrane, endoplasmic reticulum, nuclear
    membrane, and mitochondria, and then ROS induces the overexpression of HIF-1α.
    (d) E2 increases cyclin D1 protein expression and reduces the expression of p27
    and β-catenin by ERα. Overexpression of ERα or ERβ decreased the activity of PPARγ
    protein, thereby significantly promoting the proliferation and migration of thyroid
    cancer cells. TRIM16 has “anti-estrogen” activity, and its anti-estrogen action
    is mainly concentrated in ERβ.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - WNT1
  - EGFR
  - IRS2
  - SOS1
  - SOS2
  - HRAS
  - KRAS
  - NRAS
  - SERPINA4
  - PI3
  - RAF1
  - MAP6
  - CTNNB1
  - SETD2
  - HIF1A
  - IQGAP1
  - PTEN
  - AKT2
  - AKT3
  - AKT1
  - MAP2K1
  - MAP2K2
  - BCL2
  - MAPK3
  - MAPK1
  - NOX4
  - MTOR
  - TRIM16
  - NFKB1
  - NFKB2
  - REL
  - RELA
  - RELB
  - BAX
  - thyroid cancer
genes:
- word: Wnt1
  symbol: WNT1
  source: hgnc_symbol
  hgnc_symbol: WNT1
  entrez: '7471'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: IRS2
  symbol: IRS2
  source: hgnc_symbol
  hgnc_symbol: IRS2
  entrez: '8660'
- word: sos
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS1
  entrez: '6654'
- word: sos
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS2
  entrez: '6655'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: PI4,5P
  symbol: PI4
  source: hgnc_prev_symbol
  hgnc_symbol: SERPINA4
  entrez: '5267'
- word: PI3,4,5P,
  symbol: PI3
  source: hgnc_symbol
  hgnc_symbol: PI3
  entrez: '5266'
- word: RAF1
  symbol: RAF1
  source: hgnc_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: STOP
  symbol: STOP
  source: hgnc_alias_symbol
  hgnc_symbol: MAP6
  entrez: '4135'
- word: B-catenin
  symbol: BCATENIN
  source: bioentities_symbol
  hgnc_symbol: CTNNB1
  entrez: '1499'
- word: HIF-1
  symbol: HIF-1
  source: hgnc_alias_symbol
  hgnc_symbol: SETD2
  entrez: '29072'
- word: HIF-1a
  symbol: HIF1A
  source: hgnc_symbol
  hgnc_symbol: HIF1A
  entrez: '3091'
- word: (IQGAP1
  symbol: IQGAP1
  source: hgnc_symbol
  hgnc_symbol: IQGAP1
  entrez: '8826'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: МЕК1/2
  symbol: MEK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: МЕК1/2
  symbol: MEK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: Bcl-2
  symbol: Bcl-2
  source: hgnc_alias_symbol
  hgnc_symbol: BCL2
  entrez: '596'
- word: ERK1/2
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK1/2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: NOX4
  symbol: NOX4
  source: hgnc_symbol
  hgnc_symbol: NOX4
  entrez: '50507'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: TRIM16
  symbol: TRIM16
  source: hgnc_symbol
  hgnc_symbol: TRIM16
  entrez: '10626'
- word: ERK1/2
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK1/2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: Bcl-2
  symbol: Bcl-2
  source: hgnc_alias_symbol
  hgnc_symbol: BCL2
  entrez: '596'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: Вах
  symbol: BAX
  source: hgnc_symbol
  hgnc_symbol: BAX
  entrez: '581'
chemicals: []
diseases:
- word: thyroid cancer
  source: MESH
  identifier: D013964
figid_alias: PMC8113849__F1
redirect_from: /figures/PMC8113849__F1
figtype: Figure
---
